Skip to main content

Thomas Kassberg

Equibles does not estimate personal net worth.

About Thomas Kassberg

The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $2,456,501 for Thomas Kassberg in fiscal 2019, including a base salary of $474,000. Disclosed compensation is on record for 3 fiscal years.

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Ultragenyx Pharmaceutical Inc. (RARE) $474,000 $2,456,501
2018 Ultragenyx Pharmaceutical Inc. (RARE) $441,340 $1,692,660
2017 Ultragenyx Pharmaceutical Inc. (RARE) $418,443 $2,331,661

Recent activity

No call appearances or filed executive changes recorded yet.